You are in : Home » Results & submissions » Select UOA » 1 - Clinical Medicine » View submission: Institute of Cancer Research » Outputs » Detail

Output details

1 - Clinical Medicine

Institute of Cancer Research

Return to search Previous output Next output

Output 28 of 298 in the submission

Article title

Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial

Type

D - Journal article

DOI

10.1016/S1470-2045(12)70508-9

Title of journal

LANCET ONCOLOGY

Article number

Volume number

Issue number

First page of article

ISSN of journal

1470-2045

Year of publication

2013

URL

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000313045900045&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9

Number of additional authors

Additional information

a. The author made a substantial contribution to the conception and design of the study. The author made a substantial contribution to the organisation of the conduct of the study. The author made a substantial contribution to carrying out the study (including acquisition of study data). The author made a substantial contribution to analysis and interpretation of study data. b. The author helped draft the output.

Interdisciplinary

Cross-referral requested

Research group

None

Citation count

Proposed double-weighted

Double-weighted statement

Reserve for a double-weighted output

Non-English

English abstract